Lista de obras - Esra A Akbay - Dominio Público Uruguay

Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors

artículo científico publicado en 2013

Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints.

artículo científico publicado en 2016

Assessing Therapeutic Efficacy of MEK Inhibition in a KRASG12C-Driven Mouse Model of Lung Cancer

artículo científico publicado en 2018

Autochthonous murine models for the study of smoker and never-smoker associated lung cancers

artículo científico publicado en 2018

Cell-autonomous immune gene expression is repressed in pulmonary neuroendocrine cells and small cell lung cancer

artículo científico publicado en 2021

Clinical implications of monitoring nivolumab immunokinetics in non-small cell lung cancer patients

artículo científico publicado en 2018

Co-clinical quantitative tumor volume imaging in ALK-rearranged NSCLC treated with crizotinib.

artículo científico publicado en 2016

Co-clinical trials demonstrate superiority of crizotinib to chemotherapy in ALK-rearranged non-small cell lung cancer and predict strategies to overcome resistance

artículo científico

Cooperation between p53 and the telomere-protecting shelterin component Pot1a in endometrial carcinogenesis.

artículo científico publicado en 2012

Corrigendum: Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer

artículo científico publicado en 2015

D-2-hydroxyglutarate produced by mutant IDH2 causes cardiomyopathy and neurodegeneration in mice

scientific article published on March 2014

Development of Selective Covalent Janus Kinase 3 Inhibitors.

artículo científico publicado en 2015

Differential roles of telomere attrition in type I and II endometrial carcinogenesis.

artículo científico publicado en 2008

Dysfunctional telomeres trigger cellular senescence mediated by cyclic GMP-AMP synthase

artículo científico publicado en 2020

Efficacy of BET bromodomain inhibition in Kras-mutant non-small cell lung cancer

scientific article published on 17 September 2013

Erratum: Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2.

artículo científico publicado en 2017

Genomewide discovery and classification of candidate ovarian fertility genes in the mouse

artículo científico publicado en 2007

Identification and characterization of an alternative cancer-derived PD-L1 splice variant

artículo científico publicado en 2018

Image-guided radiotherapy platform using single nodule conditional lung cancer mouse models

artículo científico publicado en 2014

Interleukin-17A Promotes Lung Tumor Progression through Neutrophil Attraction to Tumor Sites and Mediating Resistance to PD-1 Blockade

artículo científico publicado en 2017

JAK2/IDH-mutant-driven myeloproliferative neoplasm is sensitive to combined targeted inhibition

artículo científico publicado en 2018

JAK2/IDH-mutant-driven myeloproliferative neoplasm is sensitive to combined targeted inhibition.

artículo científico publicado en 2018

Kinase domain activation of FGFR2 yields high-grade lung adenocarcinoma sensitive to a Pan-FGFR inhibitor in a mouse model of NSCLC

artículo científico publicado en 2014

Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2.

artículo científico publicado en 2017

Loss of Lkb1 and Pten leads to lung squamous cell carcinoma with elevated PD-L1 expression

artículo científico publicado en 2014

Multiple interaction domains in FtsL, a protein component of the widely conserved bacterial FtsLBQ cell division complex.

artículo científico publicado en 2010

Polymerase-mediated ultramutagenesis in mice produces diverse cancers with high mutational load.

artículo científico publicado en 2018

STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment.

artículo científico publicado en 2016

Somatic LKB1 mutations promote cervical cancer progression

artículo científico publicado en 2009

Suppression of Myeloid Cell Arginase Activity leads to Therapeutic Response in a NSCLC Mouse Model by Activating Anti-Tumor Immunity

artículo científico publicado en 2019

Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor

artículo científico publicado en 2014

The impact of the MYB-NFIB fusion proto-oncogene in vivo.

artículo científico publicado en 2016

Lista de obras de Esra A Akbay

Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors

Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints.

Assessing Therapeutic Efficacy of MEK Inhibition in a KRASG12C-Driven Mouse Model of Lung Cancer

Autochthonous murine models for the study of smoker and never-smoker associated lung cancers

Cell-autonomous immune gene expression is repressed in pulmonary neuroendocrine cells and small cell lung cancer

Clinical implications of monitoring nivolumab immunokinetics in non-small cell lung cancer patients

Co-clinical quantitative tumor volume imaging in ALK-rearranged NSCLC treated with crizotinib.

Co-clinical trials demonstrate superiority of crizotinib to chemotherapy in ALK-rearranged non-small cell lung cancer and predict strategies to overcome resistance

Cooperation between p53 and the telomere-protecting shelterin component Pot1a in endometrial carcinogenesis.

Corrigendum: Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer

D-2-hydroxyglutarate produced by mutant IDH2 causes cardiomyopathy and neurodegeneration in mice

Development of Selective Covalent Janus Kinase 3 Inhibitors.

Differential roles of telomere attrition in type I and II endometrial carcinogenesis.

Dysfunctional telomeres trigger cellular senescence mediated by cyclic GMP-AMP synthase

Efficacy of BET bromodomain inhibition in Kras-mutant non-small cell lung cancer

Erratum: Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2.

Genomewide discovery and classification of candidate ovarian fertility genes in the mouse

Identification and characterization of an alternative cancer-derived PD-L1 splice variant

Image-guided radiotherapy platform using single nodule conditional lung cancer mouse models

Interleukin-17A Promotes Lung Tumor Progression through Neutrophil Attraction to Tumor Sites and Mediating Resistance to PD-1 Blockade

JAK2/IDH-mutant-driven myeloproliferative neoplasm is sensitive to combined targeted inhibition

JAK2/IDH-mutant-driven myeloproliferative neoplasm is sensitive to combined targeted inhibition.

Kinase domain activation of FGFR2 yields high-grade lung adenocarcinoma sensitive to a Pan-FGFR inhibitor in a mouse model of NSCLC

Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2.

Loss of Lkb1 and Pten leads to lung squamous cell carcinoma with elevated PD-L1 expression

Multiple interaction domains in FtsL, a protein component of the widely conserved bacterial FtsLBQ cell division complex.

Polymerase-mediated ultramutagenesis in mice produces diverse cancers with high mutational load.

STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment.

Somatic LKB1 mutations promote cervical cancer progression

Suppression of Myeloid Cell Arginase Activity leads to Therapeutic Response in a NSCLC Mouse Model by Activating Anti-Tumor Immunity

Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor

The impact of the MYB-NFIB fusion proto-oncogene in vivo.